Change of Board Responsibilities

Summary by AI BETAClose X

Ondo InsurTech Plc announced that Gregory Mark Wood CBE has transitioned from Non-Executive Chairman to Executive Chairman, effective immediately. This strategic move aims to leverage his extensive prior experience, including leadership roles at Prudential UK and AXA UK, to provide enhanced support to CEO Craig Foster as the company pursues commercial expansion. Mark Wood currently holds 2,534,652 Ondo shares, representing 1.69% of the company's issued share capital.

Disclaimer*

Ondo InsurTech PLC
23 April 2026
 

23 April 2026

Ondo InsurTech Plc

("Ondo" or the "Company")

Change of Board Responsibilities

 

Ondo InsurTech Plc (LSE: ONDO), a leading provider of claims prevention technology for home insurers, announces that Gregory Mark Wood CBE, Non-Executive Chairman of the Company, has assumed the role of Executive Chairman with immediate effect. The Board believes that Mark's extensive prior experience, including as Chief Executive Officer of Prudential UK and CEO of AXA UK, will be of considerable value to the Company in an executive function.

 

Mark has acted as Non-Executive Chairman since the Company's admission in 2022. This change in structure will provide additional support to Craig Foster, the Company's Chief Executive Officer, as the Company continues to pursue its commercial expansion.

 

Mark Wood currently owns 2,534,652 Ondo shares, representing 1.69% of the Company's issued share capital.

 

- Ends -

ENQUIRIES

For further information, please visit www.ondoplc.com or contact the following:

 

 Ondo InsurTech Plc

Mark Wood, Executive Chair

Craig Foster, CEO

Kevin Withington, CFO

 

+44 (0) 800 783 9866

 




Singer Capital Markets

(Broker & Financial Advisor)

 

Charles Leigh-Pemberton

Jen Boorer

James Todd

Anastassiya Eley

 

+44 (0) 20 7496 3000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings